Protective effect of melatonin against chlorpromazine-induced liver disease in rats

Saudi Medical Journal

Volumn 27, Issue 10, 2006, Pages 1477-1482

  Sulaiman, Amaal A ^a   Al Shawi, Nada N ^a   Jwaied, Ahmed H ^a   Mahmood, Dalaram M ^b   Hussain, Saad A ^a  

^a UNIVERSITY OF BAGHDAD   (Iraq)

^b BAGHDAD TEACHING HOSPITAL   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHLORPROMAZINE; GLUTATHIONE; MALONALDEHYDE; MELATONIN; ANTIOXIDANT; DOPAMINE RECEPTOR BLOCKING AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; IRAQ; LIVER DISEASE; LIVER FUNCTION; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SINGLE DRUG DOSE; TISSUE HOMOGENATE; TISSUE LEVEL; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; LIVER; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; CHLORPROMAZINE; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; FEMALE; LIVER; LIVER DISEASES; MALE; MELATONIN; OXIDATIVE STRESS; RATS;

EID: 36048972557     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Larrey D, Erlinger S. Drug-induced cholestasis. Baillieres Clin Gastroenterol 1988; 2: 423-452.
2. Selim K, Kaplowitz N. Hepatotoxicity of psychotropic drugs. Hepatology 1999; 29: 1347-1351.
3. Samuels AM, Carey MC. Effects of chlorpromazine hydrochloride and its metabolites on Mg+2 and Na+/K+ ATPase activities of canalicular-enriched rat liver plasma membranes. Gastroenterology 1978; 74; 1183-1190.
4. Keefe EB, Blankenship NM, Scharchmid BF. Alteration of rat liver plasma membrane fluidity and ATPase activity by chlorpromazine hydrochloride and its metabolites. Gastroenterology 1980; 79: 222-231.
5. Tan DX, Chen LD, Poeggler B. Melatonin: A potent endogenous hydroxyl radical scavenger. Endocrine J 1993; 1: 57-60.
6. Reiter RJ, Tan DX, Ocuna C. Actions of melatonin in the reduction of oxidative stress. J Biomed Sci 2000; 7: 444-458.
7. Ohta Y, Kongo M, Sasaki E, Isiguro I, Harada N. Protective effect of melatonin against alpha-naphthylisothiocyanate-induced liver injury in rats. J Pineal Res 2000; 29: 15-23.
8. Calvo JR, Reiter RJ, Garcia JJ, Ortiz GG, Tan DX, Karbownik M, Characterization of the protective effects of melatonin and related indoles against alpha-naphthylisothiocyanate-induced liver injury in rats. J Cell Biochem 2001; 80: 461-470.
9. Valame SP, Tanksal OK, Wet UK. Liver function tests in rats-effects of prolonged administration of some drugs used clinically. Find J Pharmac 1974; 6: 128-133.
10. Buge JA, Aug SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
11. Ellman GL. Tissue sulfhydryl group. Arch Biochem Biophys 1959; 82: 70-77.
12. Reitman S, Frankle S. A colorimetric method for the determination of serum glutamic oxalacetic and pyruvic transaminases. Am J Clin Path 1957; 28: 56-63.
13. Walter MI, Gerarde RW. Standardizations in bilirubin assays. Microchem J 1970; 15: 231.
14. Bauer JD, Ackermann PG, Toro G. Clinical Lab methods. 2nd ed. Saint Louis: The C.V. Mosby Company; 1978, p. 813-817.
15. Larrey D, Erlinger S. Drug- induced cholestasis. Baillieres Clin Gastroenterol 1988; 2: 423-452.
16. Lammert F, Matern S. Hepatic diseases caused by drugs. Schweiz Rundsch Med Prax 1997; 86: 1167-1171.
17. Singh S, Shachleton G, Ah-sing E, Chakaporty J, Bailey ME. Antioxidant defense in the bile duct ligated rat. Gastroenterology 1992; 103: 1625-1629.
18. Parola M, Leonardnzzi G, Albano E, Poli G, Diazani MU. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long standing cholestasis, Free Radic Biol Med 1996; 20: 351-359.
19. Ohta Y, Kongo M, Sasaki E, Harada N. Change in hepatic antioxidant defense system with liver injury development in rats with single α-naphthylisothiocyanate intoxication. Toxicology 1999; 39: 265-275.
20. Toler MS. Oxidative stress plays an important role in the pathogenesis of drug-induced retinopathy. Experimental Biology and Medicine 2004; 229: 607-615.
21. Casini A, Ceni E, Salzano R. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: Role of nitric oxide. Hepatology 1997; 25: 361-367.
22. Jean PA, Bailic MB, Roth RA. α-naphthylisothicyanate-induced elevation of biliary glutathione. Biochemical Pharmacology 1995; 39: 197-202.
23. Jean PA, Roth RA, Naphthylisothiocyanate disposition in bile and its relationship to liver glutathione and toxicity. Biochemical Pharmacology 1995; 50: 1469-1474.
24. Dahm LJ, Roth RA. Protection against α-naphthylisothiocyanate-induced liver injury by decreased hepatic non-protein sulfhydryl contents. Biochemical Pharmacology 1991; 42: 1181-1188.
25. Zang LY, Goma G, Garder H. Vallathan V. Scavenging of reactive oxygen species by melatonin. Bioch Biophys Acta 1998; 1425: 469-477.
26. Marshall KA, Reiter RJ, Poeggeler B, Arnoma OI, Halliwell B. Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med 1996; 21: 307-315.
27. Lui F, NG TB. Effect of pineal indoles on activities of the antioxidant defense enzymes, SOD, CAT and GSR and levels of reduced and oxidized GSH in rat tissues. Biochem Cell Biol 2000; 78: 447-453.
28. Jang H. Jeong D, Ahn S, Yoon C, Jeong, S, Jin S, et al. Effect of Chlorpromazine. HCL on the structural parameters of bovine brain membranes. J Biochem Mol. Biol 2004; 37: 603-611.
29. Mung WH. Salo R, Briones DF. Cytotoxic effects of neuroleptic drugs. Psychopharmacology 1987; 91: 182-188.
30. Lewis JH, Zimmerman HJ. Drug and Chemicals-induced cholestasis. Clin Liver Dis 1999; 3: 433-463.
31. Regal RF, Bill JE, Glazer HM. Phenothiazine-induced cholestatic jaundice. Clin Pharmacol 1987; 6: 787-794.
32. Ceraulo I, Ferrugia M, Tesoriere L, Sergreto S, Livera MA, Liveri TV. Interactions of melatonin with membrane models. portioning of melatonin in AQT and lecithin reversed unicells. J Pineal Res 1999; 26: 108-112.
33. Garcia JJ, Reiter RJ, Guerrero JM, Escames G, Yu BP, Oh CS, et al Melatonin presents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997; 408: 297-308.
34. Garcia JJ, Reiter RJ, Ortiz GG, Oh CS, Tang K, Yu BD, et al. Melatonin enhances tamoxifen's ability to prevent the reduction in microsomal membrane fuidity induced by lipid peroxidation. J Memb Biol 1998; 162: 59-65.
35. Aust S, Thalhammer T, Humpeler S, Jager W, Kimpfinger M, Tucek G, et al. The Melatonin receptor subtype MT1 is expressed in human gall bladder epithelia. J Pineal Res 2004; 3: 43-48.
36. Vairetti M, Ferrigo A, Bertone R, Rizzo V, Richelm P, Berte F, et al. Exogenous melatonin enhances bile flow and ATP levels after cold storage and reperfusion in rat liver: Implications for liver transplantation. J Pineal Res 2005; 38: 223-230.
37. James H. Lewis NM. Drug-induced liver disease. Med Clin North Am 2000; 84: 1275-1311.
38. Padillo FJ, Cruz A, Naarrete C, Bujalance I, Briceno J, Gallardo JI, et al. Melatonin prevents oxidative stress and hepatocyte cell death induced by experimental cholestasis. Free Radic Res 2004; 38: 697-704.
39. Sahna E, Paraakpinar H, Vardi N, Cigremis Y, Acet A. Efficacy of melatonin as protectant against oxidative stress and structural changes in liver tissue in pinealectomized rats. Acta Histochemica 2004; 106: 331-336.